Case Study: a leading pharmaceutical company capitalizes on M&A activity with S&P Global Market Intelligence brokerage research

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

A leading pharmaceutical company needed to identify joint venture and acquisition targets but required broader access to analyst insights on potential companies of interest. To meet this challenge, the firm partnered with S&P Global.

S&P Global provided its brokerage research service, giving the M&A teams the valuable investment analysis they needed. This equipped them with critical intelligence to capitalize on the rebounding market, enabling them to make more informed and timely decisions on M&A activity.